ProBio is a global CDMO dedicated to accelerating the development of advanced biologics and cell and gene therapies from early discovery through commercialization. We partner with biotech and pharmaceutical organizations to deliver flexible, end-to-end solutions, including biologics discovery, lead optimization, and full CMC and GMP manufacturing across plasmid DNA, viral vectors, mRNA, and biologics. Our integrated platform is designed to streamline timelines while maintaining the highest standards of quality and regulatory compliance, enabling seamless progression from early research to clinical milestones. We are also uniquely positioned to support investigator-initiated trials through direct partnerships with clinical CROs. With deep technical expertise and a highly collaborative approach, ProBio supports programs at every stage, allowing innovators to stay focused on advancing meaningful therapies.